AMERICAN HIP INSTITUTE
🇺🇸United States
Clinical Trials
8
Active:1
Completed:2
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 4
4 (50.0%)Not Applicable
2 (25.0%)Phase 2
1 (12.5%)Phase 3
1 (12.5%)Intraoperative Bone Marrow Aspirate Concentrate Injections: Evaluating Outcomes in a Randomized Controlled Trial
Phase 4
Not yet recruiting
- Conditions
- Labral TearFemoroacetabular Impingement
- Interventions
- Procedure: Hip arthroscopy
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- American Hip Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06750757
Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty
Phase 4
Not yet recruiting
- Conditions
- Osteoarthritis, Hip
- Interventions
- Drug: Saline
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- American Hip Institute
- Target Recruit Count
- 60
- Registration Number
- NCT06608914
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
Phase 4
Recruiting
- Conditions
- Femoro Acetabular Impingement
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- American Hip Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06500364
- Locations
- 🇺🇸
American Hip Institute Research Foundation, Des Plaines, Illinois, United States
Peri-Operative Testosterone Administration in Primary Hip Arthroscopy
Phase 4
Not yet recruiting
- Conditions
- Femoro Acetabular Impingement
- Interventions
- Drug: Saline
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- American Hip Institute
- Target Recruit Count
- 60
- Registration Number
- NCT06462482
Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial
Phase 3
Withdrawn
- Conditions
- Arthroplasty, Replacement, Hip
- Interventions
- Other: No Testosterone Therapy
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- American Hip Institute
- Registration Number
- NCT05722301
- Locations
- 🇺🇸
American Hip Institute Research Foundation, Des Plaines, Illinois, United States
- Prev
- 1
- 2
- Next
News
No news found